*Gbeneol J. Tombari and Philip Loole Mene


The goal of EPI is for universal access of all relevant vaccines for all targeted groups is to control disease and achieve better health for all. This research was aimed at providing a universal access of all relevant vaccines for all children in order to control disease and achieve better health for all, which will ensure significant reduction of mortality and morbidity among the children against the most common vaccine preventable diseases (such as measles, tuberculosis, pertussis, poliomyelitis and diphtheria). This study was conducted in Dagupan City and data were obtained from the City Health Office (CHO), under the Department of Health where all the records from 2014-2016 were collected. The subjects of this study were children between the ages of 0- 5years, and parents were the respondents for the concerns of children under five years. The CHO health officials were also interviewed for the concerns in the implementation and interventions of the child immunization program. Mothers of the children under five years old were interviewed on their concerns. Documents for analysis for this study were collected from the City Health Office (CHO), Dagupan City and analysed using descriptive research design. For the childhood immunization program on EPI, the following vaccines are included: BCG (Bacillus Calmette Guerin), Hep B, PENTA Vaccine- (DPT- Diphtheria, Pertussis; HEP B- Hepatitis B; Hib-Haemophilus Influenza Type B Vaccine), OPV (Oral Polio Vaccine), Measles Vaccine, MMR (Measles, Mumps, Rubella), and PCV (Pneumococcal Conjugate Vaccine). Vaccines and their Dosages administered through the EPI. The highest average dose administered based on total population was PENTA Vaccines, followed by PENTA 2 and PENTA 3. From the record, it shows that there were no PCV and ROTA Vaccines in the year 2014 and 2015. This lack of vaccine is a major constraint in the implementation of the child immunization program.

Keywords: DPT- Diphtheria, Pertussis; HEP B- Hepatitis B; Hib-Haemophilus Influenza Type B Vaccine.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    JANUARY 2020 Issue has been successfully launched on 1 January 2020.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction